We previously reported that the expression level of CLDN2 is increased in human lung adenocarcinoma tissues [15], and is involved in the increased proliferation [16], migration [17], and drug-resistance [18] of human lung adenocarcinoma A549 cells. The gene discussed is CLDN2; the disease is lung adenocarcinoma.